Harvard Bioscience Schedules First Quarter 2020 Earnings Conference Call for May 5, 2020 at 8:00 AM ET
23 avr. 2020 16h25 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2020 before the market opens on May...
Harvard Bioscience Announces Appointment of Susan Steele to Board of Directors
06 avr. 2020 16h39 HE
|
Harvard Bioscience, Inc.
Engine Capital Withdraws Director Nomination Notice For 2020 Annual Meeting of Stockholders HOLLISTON, Mass., April 06, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced...
Harvard Bioscience Introduces Next Generation Inhalation System to Aid in the Fight Against COVID-19
23 mars 2020 09h00 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 23, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) has launched an innovative technology – known as Accumulated Inhaled Aerosol (AIA) – for academic...
CORRECTION – Harvard Bioscience Announces Fourth Quarter 2019 Financial Results
26 févr. 2020 12h24 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline issued earlier today by Harvard Bioscience, Inc. (Nasdaq: HBIO), please note that the table titled...
Harvard Bioscience Announces Fourth Quarter 2019 Financial Results
26 févr. 2020 07h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and twelve months ended December 31, 2019....
Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET
11 févr. 2020 17h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2019 before the market opens on...
Harvard Bioscience to attend Benchmark’s 8th Annual Discovery One-on-One Conference
21 nov. 2019 16h45 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will attend The...
Harvard Bioscience Announces Third Quarter Financial Results
05 nov. 2019 16h00 HE
|
Harvard Bioscience, Inc.
Improves adjusted operating margins while taking actions to underpin next year’s profit and growth targets Q3 Revenue of $27.4 millionQ3 Operating Loss (GAAP) of $(1.4) million; Adjusted Operating...
Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 nov. 2019 08h15 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Yash Singh being named Executive Vice President, Cellular &...
Harvard Bioscience Announces Executive Appointment
31 oct. 2019 17h10 HE
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Yash Singh has been named Executive Vice President, Cellular & Molecular...